You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Patent: 10,844,066


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,844,066
Title:2-amino-N-[7-methoxy-2, 3-dihydroimidazo-[1,2-c] quinazolin-5-yl] pyrimidine-5-carboxamides
Abstract:This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.
Inventor(s):Schwarz Thomas, Liu Ningshu, Politz Oliver, Gerisch Michael, Lang Dieter
Assignee:Bayer Pharma Aktiengesellschaft
Application Number:US16082712
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,844,066

Introduction

When analyzing a patent, particularly one like United States Patent 10,844,066, it is crucial to delve into the claims, the patent landscape, and the broader context in which the patent exists. This analysis will help in understanding the patent's significance, its position within the industry, and potential implications for competitors and innovators.

Understanding the Patent Claims

What are Patent Claims?

Patent claims are the legal definitions of the invention for which the patent applicant is seeking protection. These claims must be clear, concise, and fully supported by the description in the patent specification[4].

Analyzing the Claims of US Patent 10,844,066

To analyze the claims of US Patent 10,844,066, one must review the patent document itself. Here are some key steps:

  • Identify the Independent and Dependent Claims: Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.
  • Determine the Scope of Protection: The claims define the boundaries of what is protected by the patent. Narrow claims may offer less protection but are easier to defend, while broad claims offer more protection but are harder to defend.
  • Review Prior Art: The examiner's review of prior art during the prosecution process is crucial. This can be found in the patent's file wrapper, which includes the arguments between the applicant and the examiner[4].

The Patent Landscape

What is the Patent Landscape?

The patent landscape refers to the collection of patents and patent applications related to a specific technology or industry. Analyzing this landscape helps in understanding the competitive environment and identifying trends and gaps.

Technology Classification

Patents are classified into various technology fields. For example, the USPTO uses a classification system that aggregates over 500 technology classes into broader fields such as Chemical, Drugs and Medical, Electrical and Electronics, and more[1].

Competitive Intelligence

Reviewing the patent landscape provides valuable competitive intelligence. It helps in identifying who is innovating, what technologies are being developed, when key milestones were achieved, and where the industry is heading[4].

The Role of the USPTO and Patent Prosecution

The USPTO's Role

The United States Patent and Trademark Office (USPTO) is responsible for reviewing patent applications and granting patents. The USPTO's internal databases and the Patent Application and Information Retrieval (PAIR) system provide essential records for analyzing patent prosecution histories[1].

Patent Prosecution Process

The prosecution process involves several stages, including the initial filing, examination, and potential continuation procedures. The file wrapper of a patent contains detailed discussions between the applicant and the examiner, which can provide insights into the patentability of the claims[4].

Continuation Procedures and Their Impact

Types of Continuation Procedures

Continuation procedures, such as Requests for Continued Examination (RCEs) and continuations-in-part, allow applicants to further pursue their patent applications. These procedures can significantly impact the patent landscape by extending the prosecution process and potentially broadening the scope of protection[1].

Example from In re Cellect

The case of In re Cellect highlights the complexities of continuation procedures and their impact on patent validity. The court's decision on the validity of patents in a family of continuations-in-part demonstrates the intricate nature of patent prosecution and the importance of understanding these procedures[3].

Inter Partes Review (IPR) and Post-Grant Review (PGR)

The Role of PTAB

The Patent Trial and Appeal Board (PTAB), established by the Leahy-Smith America Invents Act (AIA), provides a forum for challenging the validity of issued patents through IPR and PGR. These procedures are faster and less expensive than federal court litigation and use a lower standard of proof[2].

Implications for Patent Holders

For holders of patents like US 10,844,066, the existence of PTAB and its procedures means that their patents can be challenged more easily. This can create uncertainty and may discourage investments in patent-intensive industries[2].

Analyzing the File Wrapper

Importance of the File Wrapper

The file wrapper contains critical information about the patent application process, including arguments between the applicant and the examiner, prior art references, and administrative details. This information is essential for understanding the patent's legal status and the broader competitive landscape[4].

Example: Raptopoulos Patent

The analysis of the Raptopoulos patent (U.S. Patent No. 9,384,668) illustrates how reviewing the file wrapper can provide deep insights into the technology and the legal arguments that led to the patent's issuance. This can be particularly useful for competitive intelligence and investment decisions[4].

Statistical Insights and Trends

Patent Allowance Rates

Understanding the probability of receiving a US patent is crucial. Studies have shown that the allowance rates vary significantly depending on factors such as the technology field and the entity size of the applicant. For instance, the first-action allowance rate, progenitor allowance rate, and family allowance rate provide different perspectives on the likelihood of a patent being granted[1].

Nanotechnology Patents

The analysis of nanotechnology patents, for example, shows a significant increase in filings from the mid-1990s. This trend highlights the importance of monitoring patent filings in specific technology areas to understand industry developments[5].

Critical Analysis and Implications

Patent Quality and Litigation

The quality of patents is a critical issue. Poor-quality patents can fuel litigation, and procedures like IPR and PGR aim to improve patent quality by providing a more efficient means to challenge patent validity. However, critics argue that these procedures can create uncertainty and stifle innovation[2].

Competitive Strategy

For businesses, understanding the patent landscape and the claims of patents like US 10,844,066 is vital for competitive strategy. It helps in identifying potential threats, opportunities for collaboration, and areas for innovation.

Key Takeaways

  • Patent Claims: The claims define the scope of protection and are crucial for understanding the patent's boundaries.
  • Patent Landscape: Analyzing the patent landscape provides competitive intelligence and helps in identifying trends and gaps.
  • USPTO and Prosecution: The USPTO's processes and the file wrapper contain essential information for understanding the patent's legal status.
  • Continuation Procedures: These procedures can extend the prosecution process and impact the patent landscape.
  • IPR and PGR: These procedures provide a faster and less expensive way to challenge patent validity but can create uncertainty.
  • Statistical Insights: Understanding allowance rates and trends in specific technology areas is important for strategic decision-making.

FAQs

What is the significance of the file wrapper in patent analysis?

The file wrapper contains detailed discussions between the applicant and the examiner, prior art references, and administrative details, providing a comprehensive understanding of the patent's legal status and the broader competitive landscape[4].

How do continuation procedures impact the patent landscape?

Continuation procedures, such as RCEs and continuations-in-part, can extend the prosecution process, potentially broadening the scope of protection and impacting the validity of related patents[1][3].

What is the role of PTAB in challenging patent validity?

The Patent Trial and Appeal Board (PTAB) provides a forum for challenging the validity of issued patents through IPR and PGR, offering a faster and less expensive alternative to federal court litigation[2].

How can analyzing the patent landscape help businesses?

Analyzing the patent landscape provides valuable competitive intelligence, helping businesses identify trends, gaps, and potential threats, and informing strategic decisions on innovation and collaboration[4].

What are the implications of poor-quality patents on litigation and innovation?

Poor-quality patents can fuel litigation and create uncertainty, potentially stifling innovation and discouraging investments in patent-intensive industries[2].

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent? The Yale Journal of Law & Technology.
  2. Congressional Research Service. (2024). The Patent Trial and Appeal Board and Inter Partes Review. CRS Reports.
  3. United States Court of Appeals for the Federal Circuit. (2023). In re Cellect.
  4. IP Checkups. (2023). Patent file wrappers as a tool for competitive intelligence.
  5. OECD. (2007). Capturing Nanotechnology's Current State of Development via Patents. OECD Publishing.

More… ↓

⤷  Subscribe

Details for Patent 10,844,066

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genzyme Corporation THYROGEN thyrotropin alfa For Injection 020898 November 30, 1998 ⤷  Subscribe 2037-03-01
Recordati Rare Diseases, Inc. ELSPAR asparaginase For Injection 101063 January 10, 1978 ⤷  Subscribe 2037-03-01
Amgen Inc. EPOGEN/PROCRIT epoetin alfa Injection 103234 June 01, 1989 ⤷  Subscribe 2037-03-01
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.